Trial Profile
A Randomised Comparison of Short and Protracted Neoadjuvant Hormonal Therapy Prior to Radiation Therapy of High Risk Localized Prostate Cancer.
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Flutamide (Primary) ; Triptorelin (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 16 Dec 2011 Additional trial centre identified, inclusion and exclusion criteria amended as reported by ClinicalTrials.gov.
- 13 Dec 2011 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 13 Dec 2011 Official Title amended as reported by ClinicalTrials.gov.